Gynecologic Cancer | Tumor

CURE’s gynecologic cancer page is an extensive resource of cancer information featuring the latest gynecologic cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on gynecologic cancer.

Cancer Vaccine-Tecentriq Combo Elicits ‘Very Encouraging’ Outcomes in Advanced Cervical Cancer

May 10th 2022

Treatment with an investigational cancer vaccine plus Tecentriq was associated with positive outcomes in patients with heavily pre-treated advanced cervical cancer, according to findings from an interim analysis of a phase 2 trial.

Extraordinary Oncology Nurse, Extraordinary Person

May 7th 2022

Donna MacDonald, B.S.N., RN, OCN, CCM, goes beyond her duties as a nurse to advocate and support her patients.

First-in-Human Trial of an Investigational Cell Therapy for Advanced Gynecologic Cancers Treats First Patient

April 7th 2022

The first patient was dosed in an early-phase trial evaluating the investigational cell therapy DeTIL-0255 for the treatment of advanced ovarian, cervical and endometrial cancer.

Here We Go Again: After Already Overcoming Multiple Obstacles This Year, Another Cancer Treatment Regimen is on My Horizon

April 2nd 2022

The year 2022 has already been filled with obstacles and heartache — as well plans for a new cancer treatment — but I’m putting away the bad thoughts to get ready for the fight ahead of me.

FDA’s Keytruda Approval for Subset of Advanced Endometrial Cancer Provides Patients With a ‘Practice Changing’ Treatment Option

March 29th 2022

Keytruda was well tolerated and demonstrated practice-changing responses with potential for a curative approach in a group of patients with advanced endometrial cancer, according to an expert.

Increased Use of First-Line Maintenance Treatment Is ‘Reassuring’ for Patients With Ovarian Cancer

March 28th 2022

It is essential that patients and providers discuss appropriate options for maintenance therapy after ovarian cancer, one expert explained.

Birthday Reflections on My Cancer Experience: I’m Fighting the Best I Can

March 26th 2022

Today is my birthday, and while I’ve had some unforeseen changes in my cancer treatment lately, I’m grateful to still be here to celebrate.

Imfinzi Fails to Improve Survival in Locally Advanced Cervical Cancer

March 25th 2022

AstraZeneca, the manufacturer of the drug, announced that treatment with Imfinzi plus chemoradiotherapy did not improve survival compared with standard-of-care chemoradiotherapy alone in patients with locally advanced cervical cancer.

Intravenous and Direct-to-Abdomen Chemotherapy Plus Avastin Lead to Similar Outcomes in Advanced Ovarian Cancer

March 23rd 2022

There were no major differences in survival when comparing intravenous and intraperitoneal chemotherapy plus Avastin in patients with advanced ovarian cancer, research shows.

Treatment With Novel Drug Induces Promising Response Rates in Ovarian Cancer Subgroup

March 22nd 2022

“These results position mirvetuximab soravtansine to become a practice-changing, biomarker-driven, standard-of-care treatment option for patients with (high folate receptor-alpha)-positive, platinum-resistant ovarian cancer,” noted one of the study authors.

Zejula-Avastin Combo Improves Outcomes, With ‘No Impact on Quality of Life’ in High-Risk Ovarian Cancer

March 22nd 2022

Zejula plus Avastin led to promising progression-free survival rates with no new side effects for patients with newly diagnosed, advanced ovarian cancer.

FDA Approves Second Keytruda Indication for Subset of Advanced Endometrial Cancer

March 21st 2022

The FDA’s approval of Keytruda is indicated for patients with advanced endometrial carcinoma with specific genetic characteristics whose disease progressed after systemic therapy and are not suitable for surgery or radiation.

Cancer Survivors Obtain Similar Immune Response to HPV Vaccine as General Population

December 16th 2021

The vaccine, which protects patients from seven different strains related to HPV-related cancers, may be considered part of routine oncology care for survivors.

Keytruda Receives FDA Approval for Firstline Treatment of Certain Patients With Cervical Cancer

October 13th 2021

The FDA approved Keytruda for use with chemotherapy with or without bevacizumab, for the treatment of a subset of patients with cervical cancer.

Effects of Early Menopause From Cancer Treatment May Be Eased With Hormone Replacement Therapy

October 6th 2021

Side effects from early-onset menopause from medical treatments may be mitigated with hormone replacement therapy.

FDA Approves Tivdak for Metastatic/Recurrent Cervical Cancer

September 20th 2021

Tivdak is a targeted therapy that showed promising results for patients with pretreated metastatic or recurrent cervical cancer.

Standard Screening Practices May Highlight Disparities in Endometrial Cancer

August 5th 2021

Transvaginal ultrasonography may inaccurately measure uterine lining in Black women, highlighting the potential to assess its use on a case-by-case basis.

FDA Approves Keytruda/Lenvima Combo for Advanced Endometrial Cancer

July 22nd 2021

The Food and Drug Administration approved Keytruda plus Lenvima for patients with advanced endometrial carcinoma whose disease had progressed after previous systemic therapy and are not candidates for surgery or radiation.

FDA Grants Accelerated Approval to Jemperli for Endometrial Cancer

April 22nd 2021

Jemperli (dostarlimab) received accelerated approval from the Food and Drug Administration for the treatment of patients with recurrent or advanced endometrial cancer whose disease has progressed on, or following, prior treatment with a platinum-containing chemotherapy and whose cancers have a specific genetic biomarker known as deficient mismatch repair.

Targeted Therapies Take Aim at Endometrial Cancer

March 17th 2021

As more is learned about the biology of endometrial cancer, new treatment possibilities emerge.

7 Recent Updates in the Field of Women's Cancers

March 8th 2021

In honor of International Women’s Day, CURE® compiled some recent news and updates in women’s cancers that patients, survivors and caregivers may have missed.

Radiation After Surgery May Lower the Risk for Disease Spread in Uterine Carcinosarcomas

February 9th 2021

Women who underwent radiation after cancer surgery had improved distant metastases-free survival rates, although this benefit was not evident in overall survival.